2 completed, 1 terminated. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow suvratoxumab: new trials by email Literature Review of suvratoxumab trials Research Report on suvratoxumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2 Suvratoxumab, Placebo - Ventilator Associated Pneumonia, Staphylococcus Aureus | Phase 3 | Terminated | Aridis Pharmaceuticals, Inc. | 24 | 2022-09-02 | 2025-03-24 |
| Study of the Efficacy and Safety of MEDI4893 MEDI4893, Placebo - Staphylococcus Aureus Pneumonia | Phase 2 | Completed | MedImmune LLC | 213 | 2014-10-10 | 2019-12-23 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4893 in Healthy Adult Subjects Placebo, MEDI4893 - Staphylococcus Aureus | Phase 1 | Completed | MedImmune LLC | 85 | 2013-01-01 | 2014-07-24 |
Staphylococcal Infections (2) · Pneumonia, Staphylococcal (1) · Pneumonia, Ventilator-Associated (1)
MedImmune LLC (2) · Aridis Pharmaceuticals, Inc. (1)
Belgium (2) · France (2) · Greece (2) · Spain (2) · United States (2) · Czechia (1) · Germany (1) · Hungary (1) · Israel (1) · Netherlands (1) · Portugal (1) · Switzerland (1)
Hasan Jafri, M.D. (1) · Howard Schwartz, M.D. (1)